Sources | Names Used |
---|---|
CTRPv2 | tretinoin:navitoclax (4:1 mol/mol) |
PharmacoGx | tretinoin:navitoclax (4:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PRR36 | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-08 |
mRNA | MYO1F | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-08 |
mRNA | ZFP14 | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-08 |
mRNA | PEX5L | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-08 |
mRNA | SHISA7 | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-08 |
mRNA | ACTL6B | CTRPv2 | pan-cancer | AAC | 0.21 | 3e-08 |
mRNA | ZNF292 | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-08 |
mRNA | SBK1 | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-08 |
mRNA | ZMIZ1 | CTRPv2 | pan-cancer | AAC | 0.21 | 4e-08 |
mRNA | VPS4B | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-08 |